Literature DB >> 21784821

Survival trends of US dialysis patients with heart failure: 1995 to 2005.

Austin G Stack1, Amir Mohammed, Alan Hanley, Arif Mutwali, Hoang Nguyen.   

Abstract

BACKGROUND AND OBJECTIVES: Congestive heart failure (CHF) is a major risk factor for death in end-stage kidney disease; however, data on prevalence and survival trends are limited. The objective of this study was to determine the prevalence and mortality effect of CHF in successive incident dialysis cohorts. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a population-based cohort of incident US dialysis patients (n = 926,298) from 1995 to 2005. Age- and gender-specific prevalence of CHF was determined by incident year, whereas temporal trends in mortality were compared using multivariable Cox regression.
RESULTS: The prevalence of CHF was significantly higher in women than men and in older than younger patients, but it did not change over time in men (range 28% to 33%) or women (range 33% to 36%). From 1995 to 2005, incident death rates decreased for younger men (≤70 years) and increased for older men (>70 years). For women, the pattern was similar but less impressive. During this period, the adjusted mortality risks (relative risk [RR]) from CHF decreased in men (from RR = 1.06 95% Confidence intervals (CI) 1.02-1.11 in 1995 to 0.91 95% CI 0.87-0.96 in 2005) and women (from RR = 1.06 95% CI 1.01-1.10 in 1995 to 0.90 95% CI 0.85-0.95 in 2005 compared with referent year 2000; RR = 1.00). The reduction in mortality over time was greater for younger than older patients (20% to 30% versus 5% to 10% decrease per decade).
CONCLUSIONS: Although CHF remains a common condition at dialysis initiation, mortality risks in US patients have declined from 1995 to 2005.

Entities:  

Mesh:

Year:  2011        PMID: 21784821      PMCID: PMC3359531          DOI: 10.2215/CJN.01130211

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: process, outcomes, and implications.

Authors:  Jonathan R Sugarman; Pamela R Frederick; Diane L Frankenfield; William F Owen; William M McClellan
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Comorbid conditions and correlations with mortality risk among 3,399 incident hemodialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  1992-11       Impact factor: 8.860

3.  A randomized evaluation of two health care quality improvement program (HCQIP) interventions to improve the adequacy of hemodialysis care of ESRD patients: feedback alone versus intensive intervention.

Authors:  William M McClellan; Emily Hodgin; Stephen Pastan; Lisa McAdams; Michael Soucie
Journal:  J Am Soc Nephrol       Date:  2004-03       Impact factor: 10.121

4.  Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.

Authors:  Santhi K Ganesh; Tempie Hulbert-Shearon; Friedrich K Port; Kim Eagle; Austin G Stack
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

5.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors.

Authors:  J D Harnett; R N Foley; G M Kent; P E Barre; D Murray; P S Parfrey
Journal:  Kidney Int       Date:  1995-03       Impact factor: 10.612

6.  Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States.

Authors:  Austin G Stack; Donald A Molony; Noor S Rahman; Akinsansoye Dosekun; Bhamidipati Murthy
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

7.  Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure.

Authors:  Christopher Chan; John S Floras; Judith A Miller; Andreas Pierratos
Journal:  Nephrol Dial Transplant       Date:  2002-08       Impact factor: 5.992

8.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

9.  Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

Authors:  Gennaro Cice; Luigi Ferrara; Antonello D'Andrea; Salvatore D'Isa; Attilio Di Benedetto; Antonio Cittadini; Pina Elvira Russo; Paolo Golino; Raffaele Calabrò
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

Review 10.  Erythropoietin should be part of congestive heart failure management.

Authors:  Donald S Silverberg; Dov Wexler; Miriam Blum; Doran Schwartz; Yoram Wollman; Adrian Iaina
Journal:  Kidney Int Suppl       Date:  2003-11       Impact factor: 10.545

View more
  4 in total

1.  Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Elaine Ku; Wei Yang; Charles E McCulloch; Harold I Feldman; Alan S Go; James Lash; Nisha Bansal; Jiang He; Ed Horwitz; Ana C Ricardo; Tariq Shafi; James Sondheimer; Raymond R Townsend; Sushrut S Waikar; Chi-Yuan Hsu
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

2.  Decision making in advanced heart failure: a scientific statement from the American Heart Association.

Authors:  Larry A Allen; Lynne W Stevenson; Kathleen L Grady; Nathan E Goldstein; Daniel D Matlock; Robert M Arnold; Nancy R Cook; G Michael Felker; Gary S Francis; Paul J Hauptman; Edward P Havranek; Harlan M Krumholz; Donna Mancini; Barbara Riegel; John A Spertus
Journal:  Circulation       Date:  2012-03-05       Impact factor: 29.690

3.  Prevalence and variation of Chronic Kidney Disease in the Irish health system: initial findings from the National Kidney Disease Surveillance Programme.

Authors:  Austin G Stack; Liam F Casserly; Cornelius J Cronin; Tetyana Chernenko; Walter Cullen; Ailish Hannigan; Rajiv Saran; Howard Johnson; Gemma Browne; John P Ferguson
Journal:  BMC Nephrol       Date:  2014-11-25       Impact factor: 2.388

Review 4.  Therapeutic Approach to Patients with Heart Failure with Reduced Ejection Fraction and End-stage Renal Disease.

Authors:  Chakradhari Inampudi; Paulino Alvarez; Rabea Asleh; Alexandros Briasoulis
Journal:  Curr Cardiol Rev       Date:  2018-03-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.